|
|
||||||||
The Journal of Neurophysiology Vol. 86 No. 6 December 2001, pp. 2845-2855
Copyright ©2001 by the American Physiological Society
Committee on Neurobiology and Department of Neurobiology, Pharmacology and Physiology, University of Chicago, Chicago, Illinois 60637
| |
ABSTRACT |
|---|
|
|
|---|
Fox, Lyle E. and Philip E. Lloyd. Evidence That Post-Tetanic Potentiation Is Mediated by Neuropeptide Release in Aplysia. J. Neurophysiol. 86: 2845-2855, 2001. Many neuromuscular and central synapses exhibit activity-dependent plasticity. The sustained high-frequency firing needed to elicit some forms of plasticity are similar to those often required to release neuropeptides. We wanted to determine if neuropeptide release could contribute to post-tetanic potentiation (PTP) and chose neuromuscular synapses in buccal muscle I3a to explore this issue. This muscle is innervated by two motor neurons (termed B3 and B38) that show PTP in response to tetanic stimulation. B3 and B38 use glutamate as their fast transmitter but express different modulatory neuropeptides. B3 expresses FMRFamide, a neuropeptide that only slightly increases its own excitatory junction potentials (EJPs). B38 expresses the small cardioactive peptide (SCP), a neuropeptide that dramatically increases its own EJPs. It was our hypothesis that SCP released from B38's terminals during tetanic stimulation mediated a component of PTP for B38. Because no antagonist to SCP currently exists, we used several indirect approaches to test this hypothesis. First, we studied the effects of increasing stimulation frequency during the tetanus or lowering temperature on PTP. Both of these changes are known to dramatically increase SCP release. We found that increasing the frequency of stimulation increased PTP for both neurons; however, the effects were larger for B38. Decreasing the temperature tended to reduce PTP for B3, while increasing PTP for B38. These results were consistent with known properties of SCP release from B38. Next we selectively superfused the neuromuscular synapses with exogenous SCP to determine if this would occlude the effects of SCP released from B38 during a tetanus. We found that exogenous SCP dramatically reduced PTP for B38 but had little effect on PTP for B3. Thus our results support the hypothesis that physiological stimulation of B38 elicits PTP that is predominantly dependent on the release of SCP from its own terminals. They also demonstrate that the mechanisms underlying PTP can be very different for two motor neurons innervating the same target muscle.
| |
INTRODUCTION |
|---|
|
|
|---|
Synaptic plasticity has been
hypothesized to underlie behavioral plasticity and memory in both
vertebrates and invertebrates (Abel and Kandel 1998
;
Bailey et al. 2000a
; Byrne and Kandel
1996
; Huang et al. 1996
; Lechner and
Byrne 1998
; Milner et al. 1998
). Two
well-studied mechanisms that are capable of modulating synaptic strength are post-tetanic potentiation (PTP) and long-term potentiation (LTP). Nearly all neuromuscular and many central synapses show PTP, the
phenomenon in which synaptic potentials are potentiated for several
minutes following a high-frequency (tetanic) burst of presynaptic
action potentials. At most synapses studied, PTP is thought to be due
to an increased level of residual Ca2+ in the
presynaptic terminal (Thomson 2000
; Zucker 1989
,
1999
). This increase in residual Ca2+ is
believed to activate as yet unidentified processes that increase transmitter release. We will refer to this phenomenon as classic PTP.
Another widespread form of frequency-dependent potentiation at central
synapses is LTP. However, unlike PTP, induction of LTP is thought to
require an increase in the Ca2+ concentration in
the postsynaptic neuron that is, in many cases, mediated primarily by
N-methyl-D-aspartate (NMDA) receptors
(Bekkers and Stevens 1990
; Kullmann and
Siegelbaum 1995
; Malenka and Nicoll 1999
;
Malinow et al. 2000
).
Modulation of synaptic transmission by neuropeptide cotransmitters, at
least superficially, shares several of the characteristics of classic
PTP and LTP. The release of neuropeptide cotransmitters and the
induction of both PTP and LTP often require high firing frequencies
(Huang et al. 1996
; Kupfermann 1991
;
Zucker 1999
). Many neuropeptide cotransmitters increase
synaptic transmission with a time course similar to PTP and LTP.
Neuropeptides also can increase presynaptic or postsynaptic
Ca2+ levels by modulating the conductance of
voltage-gated Ca2+ channels or by releasing
Ca2+ from internal stores (Kaczmarek
2000
; Miller 1998
; Tse and Tse 1999
; Wickman and Clapham 1995
; Wu and
Saggau 1997
). The similarities between physiological stimuli
that induce neuropeptide release and PTP combined with the prevalent
expression of neuropeptide cotransmitters suggests that a component of
PTP in some neurons could be mediated by modulatory neuropeptides.
To investigate if neuropeptides were involved in PTP, we studied the
neuromuscular synapses of anterior buccal muscle 3 (I3a) in
Aplysia. This muscle and the motor neurons that innervate it generate rhythmic biting and swallowing movements during feeding (Church and Lloyd 1991
, 1994
; Cohen et al.
1978
; Gardner 1971
). There are several reasons
to use this preparation to study the role of modulatory neuropeptides
in PTP. First, the excitatory motor neurons that innervate I3a have
been identified (B3 and B38) (Church and Lloyd 1991
;
Church et al. 1993
). Because these neurons functionally
innervate the same muscle fibers, PTP produced by both neurons can be
assayed on the same postsynaptic target (Fox and Lloyd
1997
). Second, the transmitters used by B3 and B38 are known.
Both neurons use the same conventional fast acting transmitter,
L-glutamate (Fox and Lloyd 1999
), so
differences in PTP between B3 and B38 are unlikely to be due to release
of different conventional transmitters. However, B3 and B38 use
different modulatory neuropeptide cotransmitters. B3 expresses and
releases FMRFamide, whereas B38 expresses and releases the small
cardioactive peptide (SCP). SCP dramatically increases EJPs evoked by
B38, but not B3-evoked EJPs (Church et al. 1993
;
Fox and Lloyd 1997
; Lotshaw and Lloyd
1990
).
The mechanisms that underlie the effects of SCP have been investigated
in I3a. Both the neuronal release and application of exogenous SCP
dramatically increased cAMP levels in the muscle (Church et al.
1993
; Fox and Lloyd 2000
). Many of the
short-term modulatory effects of SCP in this preparation are mediated
by the cAMP pathway (Fox and Lloyd 2000
; Lotshaw
and Lloyd 1990
). By contrast, FMRFamide only slightly increases
EJPs evoked by either neuron. Thus the major difference between the
effects of the neuropeptide cotransmitters is quantitative. At 1 µM,
FMRFamide increases EJPs <50% while SCP increases B38-evoked EJPs
>1,000% (Church et al. 1993
; Fox and Lloyd
1997
, 1998
; Keating and Lloyd 1999
;
Lotshaw and Lloyd 1990
). So, if neuropeptide
cotransmitters participate in PTP, increases in B38-evoked EJPs could
act as a sensitive assay for the effects of SCP released during a tetanus.
It was our hypothesis that SCP released from B38's terminals during tetanic stimulation would contribute to PTP for B38. We found that PTP for B38 was much larger than PTP for B3. Because no antagonist to SCP currently exists, we used several indirect approaches to implicate the release of SCP as the mediator of PTP for B38. First, we studied the effects of stimulation frequency of the tetanus and the effects of temperature on PTP. SCP release is known to be critically dependent on these parameters. Next, we selectively superfused the neuromuscular synapses with exogenous SCP to determine if this would occlude the effects of SCP released from B38 during a tetanus. We provide evidence that a large component of PTP for B38 is mediated by SCP release.
| |
METHODS |
|---|
|
|
|---|
Animals
Aplysia californica (60-300 g) were obtained from Marinus (Long Beach, CA), maintained in circulating artificial sea water (ASW) at 16°C, and fed dried seaweed every 3 days.
Neuron stimulation
Detailed experimental methods have been described previously
(Fox and Lloyd 1997
). Briefly, animals were immobilized
with an injection of isotonic MgCl2 and the
dissection carried out in high-Ca2+ (33 mM; 3 times normal), high-Mg2+ (165 mM; 3 times normal)
ASW (termed high Ca, Mg ASW). The buccal mass and buccal ganglia were
removed and the mass bisected along the midline. Buccal nerve 2, which
contains the peripheral axons of B3 and B38, was left intact (nerve
designations, Gardner 1971
; muscle nomenclature,
Howells 1942
; also see Lloyd 1988
). The
ganglia were desheathed and superfused with
low-Ca2+ (0.5 mM; 0.05 times normal),
high-Mg2+ (110 mM; 2 times normal) ASW (termed
low Ca ASW). Neurons were normally impaled with two microelectrodes
(2-4 M
; filled with 3 M K acetate and 30 mM KCl), one to inject
current and one to monitor membrane potential. B3 and B38 were
identified by their position, size, and muscle innervation patterns
(Church et al. 1993
). Experiments were performed at room
temperature (~24°C) unless otherwise stated. Individual spikes in
motor neurons were driven by brief (10-20 ms) depolarizing current
pulses. The frequency of action potentials within a burst was usually
16 Hz. Dose response curves were carried out by alternatively
stimulating bursts in B3 and B38 at 50 s intervals (100 s intervals for
each neuron) while increasing the concentration of SCP from 0.1 to 1 µM at 20 min intervals with no intervening washes. These long
interburst intervals were used to minimize release of endogenous
neuropeptide cotransmitters (Church et al. 1993
;
Lotshaw and Lloyd 1990
; Whim and Lloyd
1990
). Burst durations were adjusted (from 0.15 to 2 s) so
that the compound EJPs evoked by B3 or B38 were similar in amplitude.
PTP experiments were performed separately for each motor neuron. Bursts
(usually 16 Hz) were stimulated in either B3 or B38 at 100 s intervals.
After recording several "control" EJPs, PTP was induced by
stimulating the neuron to fire a tetanus of 12 bursts (5-15 Hz) of 4 s
duration with 7 s interburst intervals.
Measurement of I3a EJPs
EJPs were recorded with a perfusion electrode (Church et
al. 1993
; Fox and Lloyd 1997
). The perfusion
electrode consisted of a small chamber (100 µl) and aperture (~1.5
mm) that was positioned to press firmly down on a portion of the muscle
(see Fig. 1 in Church et al. 1993
). The inside of this
electrode was perfused with ASW while the rest of the preparation was
superfused with low-Ca ASW to suppress synaptic transmission and muscle
contractions. This procedure permits the simultaneous recording from a
population of muscle fibers thereby reducing sampling bias. It also
confined the contractions to the small area of the muscle covered by
the recording chamber and thus markedly reduced movement artifacts in
the recordings. The earliest evoked muscle contractions occur after the
sixth EJP so the early EJPs in a burst are recorded in the absence of
any movement. EJPs were recorded by extracellular electrodes placed
inside and just outside the wall of the perfusion apparatus. Signals
were amplified using a Grass P15D AC amplifier. Neuropeptides were
applied in ASW to the inner chamber of the perfusion electrode so the
ganglia and the remainder of the muscle were not exposed to them.
Typical application periods were 20 min. Burst durations were adjusted
(from 0.15 to 2 s) so that the compound EJPs evoked by B3 or B38
were similar in amplitude. Temperature changes were also restricted to
the inner chamber of the perfusion electrode. ASW temperature was
controlled with a heat exchanger submerged in a water bath and was
monitored with a miniature temperature probe (Yellow Springs
Instruments No. 402) mounted in the perfusion electrode. Experiments at
16 and 24°C were performed on the same preparations, and the
direction of the temperature change was alternated.
| |
RESULTS |
|---|
|
|
|---|
Effects of tetanic stimulation of B38 resemble the effects of the bath application of SCP
Initially we compared the effects of PTP to those of the bath
application of SCP on EJPs evoked by B3 and B38. If the release of SCP
contributes significantly to PTP for B38, then the effects of the
neuropeptide should resemble, at least in part, the effects of tetanic
stimulation. First we determined the effects of exogenous SCP and
FMRFamide on EJPs evoked by B3 and B38 in the same preparation. A
perfusion electrode was used to record extracellular EJPs in a small
portion of the I3a muscle that was perfused with ASW while the
remainder of the muscle was superfused with low-Ca ASW to suppress
synaptic transmission and muscle contractions (Church et al.
1993
). This procedure permitted stable long-term recordings, rapid solution turnover, and simultaneous recordings from a population of fibers, thereby reducing sampling bias. Results from this technique are qualitatively similar to those obtained with intracellular electrodes (Fox and Lloyd 1997
). Application of 1 µM
SCP dramatically increased B38-evoked EJPs while having a much smaller
effect on those evoked by B3 (Fig. 1). By
contrast, 1 µM FMRFamide only slightly increased EJPs evoked by both
neurons. The increases produced by both SCP and FMRFamide reversed
within 1 h of washout. So if a significant component of PTP was
due to SCP release, then we would expect tetanic stimulation of B38 to
selectively potentiate its own EJPs and we would expect PTP to readily
reverse after the end of the tetanic stimulation.
|
Next we examined the heterosynaptic effects of tetanic stimulation of
B3 or B38. It was important to determine that stimulation of the motor
neurons did not release other substances that modulated the efficacy of
synaptic transmission. For example, it is possible that glutamate
released from the motor neurons could induce a lasting plasticity
similar to LTP. We found that tetanic stimulation of one of the motor
neurons had very little effect on subsequent EJPs evoked by the other
neuron (Figs. 2 and
3). Tetanic stimulation of B38 only
slightly potentiated B3-evoked EJPs [by 22 ± 8% (mean ± SE) at 8 s after the tetanus; n = 5],
which is similar to the effects observed for the application of
exogenous SCP (Fig. 6). Tetanic stimulation of B3 had an even smaller
effect on B38-evoked EJPs (potentiated by 13 ± 11%,
n = 5; Figs. 2 and 3). The effects of released
neuropeptides were expected to be quite small as exogenous SCP only
moderately increased B3-evoked EJPs (Church et al. 1993
; Fox and Lloyd 1997
) and exogenous FMRFamide has only a
small effect on B38-evoked EJPs. FMRFamide, at 1 µM, increased
B38-evoked EJPs by 40 ± 16% (n = 8). Therefore
the effects of heterosynaptic stimulation could be explained by the
release of neuropeptides expressed in B3 and B38.
|
|
Homosynaptic stimulation of B38 produced PTP that resembled the effects
of exogenous SCP application. Both neurons exhibited PTP, but the
B38-evoked EJPs were potentiated much more than those evoked by B3
(Figs. 2 and 3). When PTP was measured at 108 s after the end of
the tetanic stimulation, a period that allows more rapid processes such
as facilitation and augmentation to decay (Zucker 1989
),
tetanic stimulation of B38 potentiated B38-evoked EJPs by 342 ± 88% (n = 6) and tetanic stimulation of B3 potentiated B3-evoked EJPs by 52 ± 18% (n = 6). PTP for both
neurons typically reversed within 15 min. These results are consistent
with the hypothesis that a major component of PTP for B38 is caused by SCP release. Unfortunately, no antagonist for SCP exists, so we tested
this hypothesis indirectly. Initially we varied two parameters known to
strongly influence neuropeptide release, the frequency of stimulation
during the tetanus and temperature.
PTP is highly dependent on the frequency of tetanic stimulation
Neuropeptide release from Aplysia motor neurons is
highly dependent on firing frequency (e.g., Vilim et al. 1996
,
2000
; Whim and Lloyd 1989
, 1990
, 1994
). We
already estimated the frequency dependence of SCP release from B38 in
I3a using several indirect approaches (Church et al.
1993
). SCP release occurred at frequencies <10 Hz and
increased with higher frequencies. We examined whether the amplitude of
PTP was dependent on frequency for B3 and B38 (Fig.
4). We found that for all frequencies
tested, PTP was larger for B38 than for B3. PTP for B3 was dependent on
tetanic firing frequency; however, PTP for B38 showed a stronger
dependence on frequency (Fig. 4). The fact that PTP for B38 was larger
at all stimulation frequencies supports our hypothesis that the release of SCP from B38 mediates a major component of PTP for B38. However, it
is possible that mechanisms that underlie classic PTP also contributed
to PTP for B38. It is interesting to note that the frequencies that
elicited PTP for B38 were also shown by previous indirect measurements
to release SCP (Church et al. 1993
). For example, B38
normally fires at 10 Hz during feeding-like motor programs and this
frequency both releases SCP and produces substantial PTP.
|
PTP is highly dependent on temperature
Neuropeptide release at Aplysia neuromuscular synapses
is extremely temperature dependent, increasing dramatically at lower temperatures (Vilim et al. 1996
; Whim and Lloyd
1990
). For example, in another buccal neuromuscular preparation
from Aplysia (termed the ARC), release of SCP was directly
measured using a radioimmunoassay (RIA) during the stimulation of a
SCP-expressing motor neuron B15. Decreasing the temperature from 19 to
16°C caused a approximately fourfold increase in SCP release from
B15's terminals (Vilim et al. 1996
). Neuronal release
of SCP also potently increases cAMP levels in the ARC. Thus changes in
SCP release due to temperature can be monitored indirectly using cAMP
levels in the muscle (Whim and Lloyd 1990
). Stimulation
of B15 with a paradigm that had no effect on cAMP levels at 22°C
caused a 14 ± 5-fold increase at 16°C (Whim and Lloyd
1990
). This increase in cAMP levels is most likely due to
increased SCP release and not a change in cAMP metabolism because the
same decrease in temperature had no effect on the amplitude of the
increase in cAMP caused by exogenous SCP. Pilot studies indicated that
there is similar relationship between temperature and SCP release from
B38's terminals in the I3a muscle (Church et al. 1993
).
Therefore if SCP mediated a major component of PTP and if more SCP is
released at lower temperatures, we would also expect PTP for B38 to
increase at lower temperatures. However, before we tested the effects
of tetanic stimulation on PTP, we first determined the effects of
temperature on basal synaptic transmission.
Changing temperature can have dramatic and unpredictable effects on
synaptic transmission. Depending on the temperature range and the
preparation tested, reducing the temperature can either increase or
decrease the rest potential, input resistance, amplitude of synaptic
potentials, or excitability of the neuron (Hardingham and
Larkman 1998
; Stephens 1985
; Stephens and
Atwood 1982
; Volgushev et al. 2000a
,b
;
Weight and Erulkar 1976
). We tested the effects of
reducing the temperature 8°C, from 24 to 16°C, on EJPs evoked by
both B3 and B38. Both of these temperatures are within the normal
physiological range for Aplysia because they normally live and feed at these temperatures (Kupfermann and Carew
1974
). We found that reducing the temperature increased the
delay between the action potentials evoked in the motor neurons cell
bodies and the onset of the EJPs for both neurons. The onset of the
EJPs was delayed by 26 ± 4% for B3 and 28 ± 2% for B38
(n = 6). This increase could be due to a reduction in
the action potential conduction velocity or an increase in synaptic
delay or both. These mechanisms have been shown to function in other
systems (Baldo et al. 1983
; Charlton and Atwood
1979
; Katz and Miledi 1965
; Lester
1970
). We also found that at lower temperatures the EJP
amplitude was reduced to a similar degree for both neurons (Fig.
5). In other systems, reductions in the
amplitude of evoked synaptic potentials have been attributed to a
decrease in transmitter release that is due to conduction block of
action potentials, a reduction in the probability of evoked transmitter
release, or changes in the electrical properties of the postsynaptic
membrane (Barrett et al. 1978
; Barton and Cohen
1982
; Volgushev et al. 2000a
,b
; Weight and Erulkar 1976
). Even though the EJP amplitude was reduced, there was little effect on facilitation within a burst or the effectiveness of exogenous SCP to enhance EJPs. Facilitation within a
burst was measured as the ratio of the amplitude of the third EJP to
that of the first EJP. For B3, the third EJP was increased by 163 ± 8% over the first EJP at 24°C and by 181 ± 24% at 16°C (means ± SE; n = 6). For B38, the third EJP was
increased by 174 ± 29% at 24°C and 168 ± 21% at 16°C
(n = 6). So, for both neurons, lowering temperature did
not effect facilitation within the burst. Exogenous SCP also increased
EJPs to a similar degree at both temperatures. The effects of bath
application of two concentrations of SCP (0.1 and 1 µM) were compared
at 24 and 16°C. Experiments at both temperatures were performed on
the same preparations and the direction of the temperature shift was
varied systematically. EJPs evoked by both neurons at 16°C were
smaller than those evoked at 24°C, however, the increase produced by
SCP was essentially identical at both temperatures (Fig.
6). So, reducing the temperature had a
large effect on basal synaptic transmission, but no effect on the
facilitation within a burst or the increase in EJP amplitude produced
by exogenous SCP.
|
|
Next we tested the effects of this temperature shift on PTP. Lowering
the temperature has little effect on the amplitude of classic PTP for
several preparations from vertebrates and invertebrates (Fisher
et al. 1997
; Schlapfer et al. 1975
;
Zengel et al. 1980
). As discussed in the preceding text,
lowering temperature dramatically increases the release of SCP. Thus
reducing the temperature could potentially distinguish between classic
PTP and PTP mediated by SCP release. Experiments at both temperatures
were performed on the same preparations and the direction of the
temperature shift was varied systematically. Because PTP appeared to
plateau at higher stimulation frequencies (at 24°C; Fig. 4), we
concentrated our experiments on lower frequencies (5-10 Hz; Fig.
7). For B3, no significant PTP was
induced with 5 Hz tetanus. When a higher frequency tetanus was used,
PTP for B3 tended to be reduced at 16°C. By contrast, PTP produced by
B38 was larger at 16°C for all of the frequencies tested. At tetanus
frequencies of 5 and 7.5 Hz, PTP at 16°C was twice the amplitude of
PTP at 24°C. Also at 16°C, PTP appeared to reach a plateau in the
range of 7.5 to 10 Hz tetanic stimuli. Thus lowering the temperature
selectively increased PTP for B38 and appeared to shift the plateau to
a lower frequency. These results suggest that different mechanisms
underlie PTP for B3 and B38 and also supply indirect support for our
hypothesis that the release of SCP contributes to PTP for B38.
|
Interpreting the results of the experiments in which the temperature
was changed was complicated because PTP was measured at 108 s
after the end of the tetanic stimulation. This time point was chosen to
allow for the decay of shorter term synaptic plasticities such as
facilitation and augmentation (Zucker 1989
). However, PTP also decayed during this period, so PTP measured at 108 s was
a function of two processes; the initial amplitude of PTP and its decay
in the interval after the end of the tetanus. Thus it was possible that
the observed increase in PTP at lower temperatures was not due to a
change in initial PTP amplitude but instead was caused by a reduction
in the rate of decay of PTP. Indeed, the time constant for the decay of
PTP has been shown to be highly sensitive to temperature in both
vertebrate and invertebrate preparations (Fisher et al.
1997
; Schlapfer et al. 1975
; Zengel et
al. 1980
). For example, in central ganglia of
Aplysia, the maximum amplitude of PTP was not affected by
reducing the temperature 12°C (from 20 to 8°C), whereas the time
constant for the decay of the PTP was dramatically increased
(Schlapfer et al. 1975
). PTP for B38 at 5 Hz and B3 at
all frequencies was too small in most experiments to accurately
calculate the time constant for decay or the initial PTP amplitude.
However, we were able to plot the decay of PTP for B38 at frequencies
>5 Hz and extrapolate the initial PTP amplitude at the end of the
tetanus. The decay of PTP from 108 to 1,008 s was well fit by a single
exponential at both temperatures. The 8 s time point was always higher
than the extrapolated initial PTP (Fig.
8), presumably reflecting the
contribution of other processes such as augmentation and consequently
this time point was not used. The initial PTP amplitude (y
intercept) and the time constants for decay were determined. We found
that the initial PTP amplitude was increased at 16°C for B38,
2.0 ± 0.2-fold at 7.5 Hz and 1.8 ± 0.4-fold at 10 Hz
(n = 8). Surprisingly, there was no effect of
temperature on the decay of PTP for B38 at either frequency (Fig. 8).
So, the increase in PTP measured at 108 s was due to an increase
in the initial PTP amplitude and not a change in the time constant for
its decay.
|
Exogenous SCP occludes a large component of PTP for B38
Currently no SCP antagonist exists, so we determined if exogenous SCP would occlude the effects of released SCP and thereby selectively reduce PTP observed after tetanic stimulation of B38. We used two concentrations of exogenous SCP, 0.1 and 1.0 µM, and these experiments were done at 24°C. One potential problem with this approach is that SCP itself potently increases EJPs. This raises the possibility that PTP for B38 might be reduced because the EJPs are already increased close to their maximal amplitude in the presence of SCP. To ensure that this was not the case, we initially used the lower SCP concentration. At 0.1 µM, SCP increases EJPs 263 ± 119% compared with 831 ± 210% for 1 µM SCP tested on the same preparations (n = 6; Fig. 6). We examined the effects of 0.1 µM SCP on both neurons and found that PTP was reduced dramatically for B38, whereas PTP for B3 was actually increased slightly (Figs. 9 and 10). Because exogenous SCP increased EJPs, we wanted to verify that B38-evoked EJPs were not maximally potentiated after the tetanus. We tested for this by measuring facilitation within bursts. The ratio of the amplitude of the third and first EJPs in a burst was quantified and we found that it was not changed by 0.1 µM SCP or by tetanic stimulation (Fig. 11). Indeed, it was only slightly reduced by the combination of a tetanus and 0.1 µM SCP. Thus facilitation within a burst, that presumably is too rapid to be mediated by SCP release, was not significantly changed by exogenous SCP and the effects of SCP were quite specific to PTP for B38.
|
|
|
Next the effect of a higher concentration of SCP (1 µM) was examined on PTP evoked by both neurons. At this concentration, the effects of SCP are nearly maximal. For example, application of a 10-fold higher concentration of exogenous SCP (10 µM) increases EJPs only ~20% more than 1 µM. Thus one might expect that the effects of SCP released from B38 might be fully occluded by 1 µM exogenous SCP. EJPs in 1 µM SCP were very large, so we restricted our analyses to the amplitude of the first EJP. However, the EJPs measured at 108 s after the tetanus were not near their maximal amplitude as they were only 23 ± 7% (n = 6) of the largest EJPs observed within the 4 s tetanic bursts. We found that 1 µM SCP dramatically reduced PTP for B38 while it only slightly reduced PTP for B3 (Fig. 12). It is also quite striking that in 1 µM SCP, PTP for B38 appeared similar to that observed in B3 especially at later time points (Fig. 12). So most of the PTP for B38 was selectively occluded by this high concentration of exogenous SCP thus supporting our hypothesis that it is mediated by SCP released from B38's terminals during tetanic stimulation. However, a component of PTP for B38 was not occluded suggesting that another mechanism, possibly classic PTP, also contributes. If this is the case, the second mechanism would only contribute a small component of the total PTP for B38.
|
| |
DISCUSSION |
|---|
|
|
|---|
It was our hypothesis that SCP released from B38's terminals during tetanic stimulation mediated a major component of PTP for B38. The results, albeit indirect, support this hypothesis. Increasing the frequency of stimulation in the tetanus increased PTP for both neurons, but the effect was more pronounced for B38. Thus changing the tetanus frequency did not expose differences in the mechanisms that underlie PTP for B3 or B38. This was probably due to the fact that the amplitude of classic PTP and neuropeptide release both increase with the frequency of stimulation in the tetanus.
Reducing the temperature, however, proved to be a useful procedure to
distinguish between the mechanisms that underlie PTP for B3 and B38.
Decreasing the temperature tended to reduce PTP for B3, while
increasing PTP for B38. Thus different mechanisms appear to be
responsible for PTP in the two motor neurons. We suspect that the
differences in PTP are due to the release of SCP for the following
reasons. In Aplysia, decreasing the temperature has been
shown to increase SCP release in another buccal muscle (the ARC). SCP
release was detected directly using a RIA or indirectly by measuring
its effects on cAMP levels in the ARC (Vilim et al. 1996
; Whim and Lloyd 1990
). A similar
relationship between temperature and the effects of SCP released from
B38 on cAMP levels was also observed for the I3a muscle (Church
et al. 1993
). We also found that the effectiveness of SCP at
increasing EJPs was identical for both temperatures tested. That is,
application of exogenous SCP increased B38-evoked EJPs the same amount
at both 16 and 24°C. It may seem surprising that the increase
produced by SCP was essentially identical at both temperatures;
however, it is mediated by cAMP and previous studies in the ARC have
shown that exogenous SCP increases the cAMP levels in the muscle fibers
to the same degree at both 16 and 22°C (Whim and Lloyd
1990
). Taken together, these results suggest that the
mechanism(s) that underlie PTP for B38 were different from those for B3
and that it is possible that PTP for B3 and a small component of PTP
for B38 is a form of classic PTP, whereas most of the PTP for B38 is
mediated by SCP released from its terminals. Surprisingly, we found
that the decay rates of PTP for B38 were essentially identical at 16 and 24°C. This suggests that the rate-limiting mechanism underlying
the decay of PTP is relatively unaffected by temperature over this
range. One possible explanation for this observation is that the decay of PTP is limited by the diffusion of SCP away from the synapse, a
process that would be essentially independent of temperature over this
small range. Indeed, it is likely that diffusion is the primary
mechanism used to reduce SCP concentrations since the SCP receptors do
not desensitize in this system and buccal muscles show no uptake or
proteolysis of SCP (Whim and Lloyd 1989
).
Application of exogenous SCP also proved to be a useful procedure to
distinguish between the mechanisms that underlie PTP and supported the
hypothesis that most of the PTP for B38 was due to SCP release.
Exogenous SCP occluded much of the PTP for B38 and presumably the
effects of SCP released from B38, but there was a small component of
PTP for B38 that was not occluded and was similar to PTP for B3.
Indeed, in the presence of 1 µM SCP, PTP for B38 was similar to that
for B3. EJPs evoked by both neurons were increased by exogenous SCP, so
it was possible that the increase in PTP was smaller because the
control EJPs (before the tetanus) in SCP were larger. This clearly was
not the case for the lower SCP concentration as facilitation within
bursts still occurred in 0.1 µM SCP. Indeed, even though EJP
amplitude increased in SCP or after the tetanic stimulation,
facilitation within bursts was essentially unchanged. EJP amplitude
also was not maximal in the experiments using 1 µM SCP because much
larger EJPs were observed during the long tetanic bursts. Although SCP
appears to be acting by occluding the effects of endogenously released SCP, we cannot rule out the possibility that it is acting through other
unrelated mechanisms. It is interesting to note that PTP was elicited
using a stimulation paradigm that was designed to emulate active
feeding (Church and Lloyd 1994
) and that at least the
lower concentration of SCP (0.1 µM) used to occlude PTP may occur in
vivo. Thus physiological activity in B38 may elicit PTP that is
predominantly dependent on the release of SCP from its own terminals.
Even though many other mechanisms can modulate the strength of central
and peripheral synapses in Aplysia, we do not believe that
they significantly contributed to PTP in this system. Both activity-dependent and -independent heterosynaptic enhancement of
synaptic transmission have been described for central and peripheral synapses in Aplysia. However, heterosynaptic mechanisms did
not contribute to the PTP produced by tetanic stimulation because neuronal activity in the I3a preparation was precisely controlled by
removing all of the ganglia except for the buccal ganglia, suppressing
ongoing activity in the buccal ganglion with low-Ca ASW, and
controlling the activity of the motor neurons with intracellular electrodes. In the absence of motor neuron stimulation, little activity
was detected with the perfusion electrode. Instead, it appears that
PTP, at least for B38, was produced by two activity-dependent homosynaptic mechanisms; classic PTP and potentiation of EJPs by the
release of SCP from B38's terminals. Other forms of activity-dependent homosynaptic plasticity like long-term potentiation (LTP) or activation of presynaptic autoreceptors for glutamate, the fast-acting
conventional transmitter, do not appear to significantly contribute to
the PTP at these synapses. A phenomenon very similar to LTP has been described for Aplysia central synapses, however, it is
unlikely to contribute to PTP at I3a because the tetanic stimulation
used to evoke PTP did not evoke significant LTP. In addition, PTP for B3 or B38 decayed with a time constant of ~8 min, whereas
conventional LTP lasts for more than an hour for Aplysia
sensory neurons (Lin and Glanzman 1994
; Murphy
and Glanzman 1997
). The occlusion by SCP of most PTP for B38
also suggests that autoreceptors for glutamate do not contribute to
this component of PTP. However, it is possible that activation of
glutamate receptors underlies a small component of PTP. We could not
determine whether the effects of PTP were pre- or postsynaptic.
However, this system warrants further study because excitatory
presynaptic autoreceptors appear to be quite rare, especially for
neuropeptide cotransmitters (Juaneda et al. 2000
;
Malcangio and Bowery 1999
; Miller 1998
;
Wu and Saggau 1997
), and this system may allow the
examination of an understudied mechanism of neuromodulation.
Many mechanisms converge to enhance the strength of the I3a
neuromuscular synapses including facilitation, classic PTP, modulation by neuropeptide cotransmitters, and heterosynaptic facilitation by
modulatory serotonergic neurons (Church et al. 1993
;
Fox and Lloyd 1997
, 1998
; Lotshaw and Lloyd
1990
). Here we have described the convergence of two forms of
synaptic enhancement, classic PTP and the homosynaptic modulation by a
neuropeptide cotransmitter. However, the convergence of modulatory
mechanisms is not unique to neuromuscular synapses in
Aplysia. Several activity-dependent and -independent
mechanisms interact to modulate the strength of sensory neuron synapses
in Aplysia. For example, three different Ca2+-dependent mechanisms operate on similar time
scales to enhance the strength of these synapses. One mechanism,
classic PTP, acts presynaptically, whereas the other two mechanisms
elevate the Ca2+ concentration in the
postsynaptic neuron by pathways that are both dependent and independent
of N-methyl-D-aspartate receptor activation
(Bao et al. 1997
, 1998
; Lin and Glanzman
1994
; Schaffhausen et al. 2001
; Walters
and Byrne 1984
). Persistent forms of synaptic enhancement also
converge to modulate sensory neuron synapses (Bailey et al.
2000a
,b
; Sutton and Carew 2000
). It is
interesting to note that we have previously identified two forms of
persistent modulation that can prime the I3a neuromuscular system and
increase the effectiveness of subsequent modulation. First 5HT causes a persistent increase in the amplitude of EJPs and contractions that
lasts many hours (Fox and Lloyd 1997
, 1998
). Although
these effects are most prominent at high-serotonin concentrations (~1 µM), they were also observed with lower concentrations (~0.1 µM) or after stimulation of the serotonergic neurons in patterns and frequencies observed during feeding-like motor programs (Fox and Lloyd 1998
; Kupfermann and Weiss 1982
). Second,
SCP application persistently increases cAMP levels and also increases
the responsiveness of the neuromuscular preparation to subsequent
activation. This persistent increase in cAMP levels is prominent at
higher concentrations of SCP (~1 µM) but was also observed at lower
concentrations (~0.1 µM). We have shown that stimulation of B38 in
patterns and frequencies observed during feeding-like motor programs,
releases SCP at concentrations that can increase EJPs, mediates the
predominant component of PTP, and may persistently increase cAMP
levels. Although the pattern and frequencies of tetanic stimulation
used in this study resembled those observed during feeding-like motor
programs, the overall duration of the tetanus was much shorter than the
duration of typical feeding episodes. PTP was induced with a tetanus
that lasted for just over a minute, and a feeding episode can last for
over an hour (Kupfermann and Carew 1974
). It is likely
that extending the duration of tetanic stimulation would also increase neuropeptide release. In fact, this has been investigated in the ARC
neuromuscular system. It was found that neuropeptide release does not
peak until the motor neuron is stimulated for 40 min. Remarkably, the
peak amount of SCP released was ~100-fold higher than the amount
released during the first few minutes of stimulation (Karhunen
et al. 2001
). So, if SCP release from B38 follows a similar
time course, longer-duration tetanic stimulation should release more
SCP, cause more PTP, and persistently elevate cAMP levels thereby
increasing the responsiveness of the system for many hours after a
feeding episode.
In conclusion, we wanted to determine whether SCP released from B38's
terminals during tetanic stimulation contributed to PTP for B38. Our
results support this hypothesis and are consistent with known
properties of SCP release in this system. Increasing the tetanus
frequency or decreasing the temperature have been shown to increase SCP
release and enhance PTP for B38. Finally, exogenous SCP dramatically
reduced PTP for B38, but had little effect on PTP for B3. Thus
physiological stimulation of B38 may elicit PTP that is predominantly
dependent on the release of SCP from its own terminals. Finally, both
the amplitude of PTP and the mechanisms underlying it can be very
different for two motor neurons innervating the same target muscle. It
is possible that the release of neuropeptides during tetanic
stimulation could contribute to PTP in other systems as well. For
example, both vertebrate and insect motor neurons express neuropeptides
that have been shown to potentiate EJPs at their respective
neuromuscular synapses (Laufer and Changeux 1989
;
Ohhashi and Jacobowitz 1988
; Uchida et al.
1990
; Zhong 1995
; Zhong and Pena
1995
). In addition, similar mechanisms may be prevalent in the
CNS because so many neurons express peptide cotransmitters.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by National Research Service Award 1-F31-MH-10656 to L. E. Fox and National Science Foundation IBN-9728453 to P. E. Lloyd.
| |
FOOTNOTES |
|---|
Address for reprint requests: P. E. Lloyd, Committee on Neurobiology, University of Chicago, 947 E. 58th St., Chicago, IL 60637 (E-mail: plloyd{at}midway.uchicago.edu).
Received 6 April 2001; accepted in final form 20 August 2001.
| |
REFERENCES |
|---|
|
|
|---|
a decade of progress?
Science
285:
1870-1874, 1999This article has been cited by other articles:
![]() |
H.-Y. Koh and K. R. Weiss Activity-Dependent Peptidergic Modulation of the Plateau-Generating Neuron B64 in the Feeding Network of Aplysia J Neurophysiol, February 1, 2007; 97(2): 1862 - 1867. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhurov and V. Brezina Temperature Compensation of Neuromuscular Modulation in Aplysia J Neurophysiol, November 1, 2005; 94(5): 3259 - 3277. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Brezina, I. V. Orekhova, and K. R. Weiss Neuromuscular Modulation in Aplysia. II. Modulation of the Neuromuscular Transform in Behavior J Neurophysiol, October 1, 2003; 90(4): 2613 - 2628. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Koh, F. S. Vilim, J. Jing, and K. R. Weiss Two Neuropeptides Colocalized in a Command-Like Neuron Use Distinct Mechanisms to Enhance Its Fast Synaptic Connection J Neurophysiol, September 1, 2003; 90(3): 2074 - 2079. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Fox and P. E. Lloyd Mechanisms Involved in Persistent Facilitation of Neuromuscular Synapses in Aplysia J Neurophysiol, April 1, 2002; 87(4): 2018 - 2030. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |